We validated the expression levels of 5 prognostic genes in the TCGA-PRAD (Supplementary Figure S2) and found that both ATCAY and GLUL were lower expressed in the tumor tissues than normal prostate tissues, while the ASNS, CAD and FPGS were overexpressed in the prostate cancer group. The gene discussed is CAD; the disease is prostate carcinoma.